Mostra el registre parcial de l'element
dc.creator | Rigopoulou, E. I. | |
dc.creator | Davies, E. T. | |
dc.creator | Parés Darnaculleta, Albert | |
dc.creator | Zachou, K. | |
dc.creator | Liaskos, C. | |
dc.creator | Bogdanos, D. P. | |
dc.creator | Rodés, J. | |
dc.creator | Dalekos, G. N. | |
dc.creator | Vergani, Diego | |
dc.date | 2011-07-07T12:30:56Z | |
dc.date | 2011-07-07T12:30:56Z | |
dc.date | 2005 | |
dc.date.accessioned | 2024-12-16T10:27:16Z | |
dc.date.available | 2024-12-16T10:27:16Z | |
dc.identifier | 0017-5749 | |
dc.identifier | http://hdl.handle.net/2445/18674 | |
dc.identifier | 583556 | |
dc.identifier | 15753539 | |
dc.identifier.uri | http://fima-docencia.ub.edu:8080/xmlui/handle/123456789/22171 | |
dc.description | with specific ANA, in particular of the IgG3 isotype, had significantly more severe biochemical and histological disease compared with those who were seronegative. None of the controls was positive. Conclusions: Disease specific ANA are present in the majority of patients with PBC when investigated at the level of immunoglobulin isotype. PBC specific ANA, in particular of the IgG3 isotype, are associated with a more severe disease course, possibly reflecting the peculiar ability of this isotype to engage mediators of damage. | |
dc.format | 5 p. | |
dc.format | application/pdf | |
dc.language | eng | |
dc.publisher | BMJ Group | |
dc.relation | Reproducció digital del document publicat a: http://dx.doi.org/10.1136/gut.2003.036558 | |
dc.relation | Gut, 2005, vol. 54, núm. 4, p. 528-532 | |
dc.relation | http://dx.doi.org/10.1136/gut.2003.036558 | |
dc.rights | (c) BMJ Publishing Group Ltd and British Society of Gastroenterology, 2005 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.source | Articles publicats en revistes (Medicina) | |
dc.subject | Autoanticossos | |
dc.subject | Malalties autoimmunitàries | |
dc.subject | Cirrosi hepàtica | |
dc.subject | Autoantibodies | |
dc.subject | Autoimmune diseases | |
dc.subject | Hepatic cirrhosis | |
dc.title | Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers | Grandària | Format | Visualització |
---|---|---|---|
No hi ha fitxers associats a aquest element. |